
CANADIAN PEPTIDE RESEARCH SUPPLY
Retatrutide
10 mgA research-stage triple receptor agonist active at GIP, GLP-1 and glucagon receptors, investigated in studies of receptor activity, energy-balance pathways, glucose regulation and metabolic signalling.
Silver cap vial
$84.99 CAD
Research topics
- GIP receptor activity
- GLP-1 receptor activity
- Glucagon receptor activity
- Metabolic signalling
Related literature
Independent scientific literature supplied for convenient reference.
Retatrutide phase 2 trialRetatrutide trialProduct classification: Supplied for laboratory research and analytical use. Product descriptions summarize research topics and do not constitute medical advice or establish suitability for any particular application.
